Currently, there are 1.44B common shares owned by the public and among those 1.43B shares have been available to trade.
The company’s stock has a 5-day price change of -0.80% and 37.58% over the past three months. FCX shares are trading -6.14% year to date (YTD), with the 12-month market performance up to 19.36% higher. It has a 12-month low price of $27.55 and touched a high of $52.23 over the same period. FCX has an average intraday trading volume of 13.33 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.61%, 8.54%, and 11.36% respectively.
Institutional ownership of Freeport-McMoRan Inc (NYSE: FCX) shares accounts for 86.44% of the company’s 1.44B shares outstanding.
It has a market capitalization of $64.90B and a beta (3y monthly) value of 1.64. The stock’s trailing 12-month PE ratio is 37.30, while the earnings-per-share (ttm) stands at $1.21. The company has a PEG of 1.67 and a Quick Ratio of 1.13 with the debt-to-equity ratio at 0.53. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.49% over the week and 2.93% over the month.
Earnings per share for the fiscal year are expected to increase by 21.01%, and 38.69% over the next financial year.
Looking at the support for the FCX, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on July 15, 2025, with the firm’s price target at $54. UBS coverage for the Freeport-McMoRan Inc (FCX) stock in a research note released on July 11, 2025 offered a Neutral rating with a price target of $50. BofA Securities was of a view on July 09, 2025 that the stock is Neutral, while Scotiabank gave the stock Sector Outperform rating on June 16, 2025, issuing a price target of $48. Wolfe Research on their part issued Outperform rating on April 16, 2025.
